Main The number of high-risk product inspections where no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further FDA action) are classified as No Action Indicated. Number Classified as NAI column 0 100 0 850

FY 2010 Overall: 6,376

Oct 2009 340 Nov 2009 474 Dec 2009 513 Jan 2010 510 Feb 2010 483 Mar 2010 673 Apr 2010 515 May 2010 569 Jun 2010 828 Jul 2010 452 Aug 2010 556 Sep 2010 463 0 850

FY 2011 Overall: 6,354

Oct 2010 475 Nov 2010 583 Dec 2010 624 Jan 2011 526 Feb 2011 489 Mar 2011 713 Apr 2011 483 May 2011 556 Jun 2011 650 Jul 2011 364 Aug 2011 518 Sep 2011 373

FY 2012 Total: 7,969

Oct 2011 691 Nov 2011 766 Dec 2011 819 Jan 2012 697 Feb 2012 725 Mar 2012 890 Apr 2012 596 May 2012 615 Jun 2012 622 Jul 2012 478 Aug 2012 607 Sep 2012 463 Sub Number of highest risk domestic inspections in the month resulting in a classification of No Action Indicated (NAI) Percent Classified as NAI 0 100 0 100

Oct 2009 50 Nov 2009 53 Dec 2009 56 Jan 2010 57 Feb 2010 55 Mar 2010 57 Apr 2010 55 May 2010 59 Jun 2010 61 Jul 2010 53 Aug 2010 59 Sep 2010 52 0 100

Oct 2010 51 Nov 2010 51 Dec 2010 55 Jan 2011 58 Feb 2011 53 Mar 2011 53 Apr 2011 51 May 2011 51 Jun 2011 54 Jul 2011 49 Aug 2011 52 Sep 2011 48

Oct 2011 65 Nov 2011 61 Dec 2011 62 Jan 2012 58 Feb 2012 59 Mar 2012 59 Apr 2012 56 May 2012 52 Jun 2012 52 Jul 2012 52 Aug 2012 57 Sep 2012 56 http://www.fda.gov/AboutFDA/Transparency/track/ucm204013.htm FDA-TRACK ORA Regional Offices Dashboard ਍††਍਍਍਍਍਍਍